Dynavax Technologies (DVAX)
(Real Time Quote from BATS)
$10.96 USD
-0.23 (-2.06%)
Updated Sep 11, 2024 01:06 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.39 | 293.16 | 76.71 | -75.24 | -152.60 |
Depreciation/Amortization & Depletion | -9.28 | 2.49 | 7.48 | 9.87 | 20.07 |
Net Change from Assets/Liabilities | 61.21 | -298.42 | 172.22 | -32.91 | -33.67 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 55.03 | 65.49 | 79.11 | 6.03 | 44.95 |
Net Cash From Operating Activities | 100.56 | 62.72 | 335.53 | -92.25 | -121.25 |
Property & Equipment | -3.10 | -6.14 | -8.48 | 2.78 | -22.40 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -7.00 | -7.00 |
Investments | -150.82 | -309.86 | 22.70 | -22.31 | -13.38 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -153.93 | -316.00 | 14.23 | -26.53 | -42.78 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.54 | 19.53 | 46.81 | 109.21 | 80.10 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -190.19 | 0.00 | 74.25 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 219.82 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.15 | 0.00 | -20.66 | 0.29 | 0.00 |
Net Cash from Financing Activities | 1.39 | 19.53 | 55.78 | 109.50 | 154.35 |
Effect of Exchange Rate Changes | 0.32 | -0.44 | -1.43 | 1.49 | -0.18 |
Net Change In Cash & Equivalents | -51.66 | -234.20 | 404.10 | -7.79 | -9.87 |
Cash at Beginning of Period | 202.21 | 436.41 | 32.31 | 40.10 | 49.97 |
Cash at End of Period | 150.56 | 202.21 | 436.41 | 32.31 | 40.10 |
Diluted Net EPS | -0.05 | 1.97 | 0.57 | -0.78 | -2.16 |
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 2.67 | -8.72 | -6.39 | -6.61 | -20.90 |
Depreciation/Amortization & Depletion | -4.54 | -2.58 | -9.28 | -6.00 | -3.82 |
Net Change from Assets/Liabilities | -37.23 | -26.12 | 61.21 | 54.56 | 46.92 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 33.14 | 20.74 | 55.03 | 44.84 | 33.47 |
Net Cash From Operating Activities | -5.97 | -16.68 | 100.56 | 86.80 | 55.67 |
Property & Equipment | -1.53 | -0.75 | -3.10 | -1.38 | -2.03 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -24.41 | 3.58 | -150.82 | -132.31 | -25.58 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -25.94 | 2.83 | -153.93 | -133.69 | -27.61 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.96 | 2.54 | 1.54 | 5.87 | 2.39 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -8.58 | -6.74 | -0.15 | -6.26 | -5.78 |
Net Cash from Financing Activities | -5.62 | -4.20 | 1.39 | -0.39 | -3.38 |
Effect of Exchange Rate Changes | -0.27 | -0.20 | 0.32 | -0.16 | 0.15 |
Net Change In Cash & Equivalents | -37.79 | -18.25 | -51.66 | -47.43 | 24.82 |
Cash at Beginning of Period | 150.56 | 150.56 | 202.21 | 202.21 | 202.21 |
Cash at End of Period | 112.77 | 132.30 | 150.56 | 154.78 | 227.03 |
Diluted Net EPS | 0.08 | -0.07 | 0.01 | 0.10 | 0.03 |